Back to search

University of Edinburgh

Mitochondrial dynamics in Parvalbumin neurons during grey matter demyelination

Abstract

dc:description.abstract

Multiple sclerosis (MS) is a demyelinating and neurodegenerative disease of the central nervous system (CNS). Demyelination of cortical grey matter (GM) correlates with increasing neurodegeneration and worsening disability. Crucially, we have no effective neuroprotective therapies that slow disease progression. Some neurons, such as parvalbumin-positive (PV) inhibitory neurons, are particularly vulnerable to this degeneration in the MS cortex. PV neurons are highly myelinated and metabolically active, heavily relying on mitochondrial oxidative phosphorylation to maintain their high firing rates. Demyelination increases neuronal energy burden and removes trophic support to the underlying axon, and as a result, mitochondrial dysfunction has been noted in MS tissue and experimental models. Therefore, we hypothesised that PV neuron mitochondria respond uniquely to demyelination, and that manipulating their metabolism may identify novel neuroprotective strategies in MS. In this thesis, I demonstrate that PV neurons remodel their mitochondrial network during chronic demyelination by examining post-mortem MS brain tissue. Focusing on grey matter lesions, mitochondria in surviving PV neurons were smaller and more spherical than in controls. To investigate this further, I evaluated the expression of mitochondrial dynamics proteins – which regulate the balance between mitochondrial fusion and fission – noting that a reduction in mitochondrial fusion protein Mitofusin 2 (MFN2) contributed to the observed change in mitochondrial morphology. The specificity of these observations was supported by analysis of a large human post-mortem transcriptomic dataset, which demonstrated that PV neurons exhibit prominent changes in mitochondrial dynamics alongside widespread respiratory chain dysfunction. To assess the response of vulnerable PV neurons to acute demyelination, I used a mouse model of focal subpial cortical demyelination at a timepoint of metabolic stress but prior to overt neuronal loss. Using high-resolution 3D microscopy, I identified a contrasting morphological shift towards enlarged and highly branched mitochondria in acutely demyelinating PV neurons. I investigated the expression of mitochondrial dynamics proteins and observed a specific increase in the fusion protein MFN2 in lesional PV neurons, concurrent with a decrease in phosphorylated Dynamin-related protein 1 (pDRP1), a key mediator of mitochondrial fission. Together, these changes contribute to the altered mitochondrial morphology observed in acutely demyelinating PV neurons and suggest a chronic decompensation of this initial fusion response during chronic demyelination. To determine whether these alterations in mitochondrial dynamics contribute to PV neuron vulnerability or represent a protective response to demyelination, I manipulated these pathways using two complementary approaches. First, I pharmacologically inhibited mitochondrial fission using mdivi-1, a small-molecule inhibitor of DRP1 that has been reported to exert neuroprotective effects. Second, I selectively altered mitochondrial dynamics in PV neurons by overexpressing Mfn2 using a Cre-dependent AAV approach in PV-Cre mice. While both interventions promote mitochondrial enlargement, they do so through distinct mechanisms: inhibition of fission versus enhancement of fusion. I found that blocking mitochondrial fission provided acute protection to PV neurons, supporting a role for mitochondrial dynamics in regulating PV neuron survival during demyelination. Overall, my findings demonstrate that mitochondrial dynamics are altered in PV neurons during grey matter demyelination. Notably, the direction of these changes differs between acute demyelination in mouse models and chronic demyelinated lesions in progressive MS, suggesting that mitochondrial remodelling may be a temporally regulated response that evolves throughout disease course. Together, these findings point to a potential therapeutic window in which targeting mitochondrial dynamics and associated metabolic pathways may promote PV neuron survival, highlighting these pathways as promising neuroprotective targets in progressive MS.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Horan, Kellie
Advisors dc:contributor.advisor
  • Williams, Anna
  • Mahad, Don

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Horan, Kellie. Mitochondrial dynamics in Parvalbumin neurons during grey matter demyelination. 2026. https://hdl.handle.net/1842/45447